Review
Jul 2026
Can baxdrostat redefine blood pressure control in resistant and uncontrolled hypertension? a systematic review, meta-analysis, and trial sequential analysis.
Baxdrostat, particularly at 2 mg, provides clinically meaningful BP reductions, and serious safety outcomes remain entirely comparable to control, which highlights a reassuring safety profile.
B. Khan, Muhammad Yahya, H. Khan et al.
· Naunyn-Schmiedeberg's Archiv... · 1 citation